Video Experimental Relacionado
Updated: Jan 8, 2026
07:54
Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
20.4K
Fenotipos de apnea obstructiva del sueño elegibles para tratamiento farmacológico
Marie Bruyneel1,2,3
1Department of Pneumology, Centre Hospitalier Universitaire (CHU) Saint-Pierre, Brussels, Belgium.
Frontiers in sleep
|December 22, 2025
Resumen
La apnea obstructiva del sueño (SAOS) es un problema de salud mundial creciente. Esta revisión explora los tratamientos farmacológicos para fenotipos específicos de SAOS, mejorando potencialmente los resultados de los pacientes y el riesgo cardiovascular.
Área de la Ciencia:
- Medicina del Sueño
- Farmacología
- Medicina Interna
Sus antecedentes:
- La apnea obstructiva del sueño (SAOS) es una preocupación de salud global prevalente y en aumento.
- La SAOS impacta significativamente la salud física, el bienestar mental y los factores socioeconómicos.
- Los tratamientos actuales como CPAP son efectivos, pero las terapias alternativas y emergentes están ganando terreno.
Objetivo del estudio:
- Revisar los datos actuales sobre fenotipos distintos de apnea obstructiva del sueño (SAOS).
- Resumir el potencial de las intervenciones farmacológicas para fenotipos específicos de SAOS.
- Explorar cómo los diferentes fenotipos de SAOS pueden responder a las terapias farmacológicas emergentes.
Principales métodos:
- Revisión de literatura de ensayos clínicos e investigación sobre fenotipos de SAOS.
- Análisis de estudios que investigan tratamientos farmacológicos para SAOS.
- Síntesis de datos sobre la heterogeneidad de la SAOS y las respuestas al tratamiento.
Principales resultados:
- La apnea obstructiva del sueño (SAOS) se presenta con diversos fenotipos clínicos.
- Estos fenotipos exhiben variaciones en comorbilidades, riesgo cardiovascular y respuestas al tratamiento.
- Los agentes farmacológicos emergentes muestran promesa para dirigirse a disfunciones específicas relacionadas con la SAOS.
Conclusiones:
- La comprensión de los fenotipos de SAOS es crucial para estrategias de tratamiento personalizadas.
- Los enfoques farmacológicos ofrecen una nueva vía para el manejo de la SAOS, particularmente en subgrupos de pacientes específicos.
- Se necesita más investigación para optimizar la selección de fármacos basada en el fenotipo de SAOS.
Palabras clave:
clasificación PALMendotipoapnea obstructiva del sueñooxibutininafenotiporeboxetinasolriamfetolrasgos tratablesMás Videos Relacionados
Videos de Conceptos Relacionados
01:21Sleep Apnea
443
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
443
01:07Narcolepsy
456
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
456
01:19Management of Insomnia
498
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
498
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
418
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
418
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
475
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
475
01:24Sleep-Wake Cycles
2.7K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.7K